A summary of daily biopharma industry news regarding the novel coronavirus trending on March 27, 2020, with the FDA now working with 220 test developers.

Scanwell Health secured exclusive rights to license and distribute a SARS-CoV-2 rapid serology test from INNOVITA for at-home use. The test takes 15 minutes to complete using the Scanwell Health app, and within hours a doctor or nurse practitioner will reach out with results and next steps.

COVID-19 has forced the life science industry to embrace digital engagement with HCPs at scale. But, remote detailing is not going to be successful unless pharma can offer value, according to OKRA Technologies.

A new campaign from Horizon Therapeutics called Down and Out Kidney sheds light on the prevalence and impact of gout in chronic kidney disease, and aims to facilitate an important conversation with nephrologists – kidney specialists – particularly during National Kidney Month (March).

Veeva Systems announced that the company is gaining widespread customer support for an antitrust lawsuit against IQVIA. Six of the largest global pharmaceutical companies were among more than 70 depositions gathered as part of the fact discovery phase of the case.

Those pesky ones and zeros lurked behind virtually every key trend in pharma marketing in 2019, and their influence will only grow in 2020.

Business updates for various pharma and life science companies around the globe.

Immersion in virtual reality may relieve some of the pain of contractions before childbirth, a small study suggests.

World Cancer Day and Ogilvy Health has made a commitment to make an impact on cancer.